SUBSCRIBE
SUBSCRIBE
News   Deals

Teva Pharmaceutical Industries Limited Expands Presence In China; Increases Equity Stake In Hualida Biotechnology To 60%

March 30, 2006 | 
1 min read
JERUSALEM--(BUSINESS WIRE)--March 30, 2006--Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that it has increased its equity ownership in Tianjin Hualida Biotechnology Co., Ltd. in Tianjin, from 45% to 60%.
Mergers & acquisitions Asia
MORE ON THIS TOPIC
AbbVie's office in South San Francisco, California
Cancer
AbbVie Scoops Up Ichnos Glenmark’s Lead Myeloma Antibody for Nearly $2B
July 10, 2025
 · 
1 min read
 · 
Dan Samorodnitsky
A hand in a medical or laboratory glove holds a laboratory flask with coins with dollar sign. Investments in laboratory research and science. Concept of profit, making money, business. Modern design. Copy space.
Gene therapy
AstraZeneca Gains More Gene Therapy AAVs in JCR Deal Worth up to $825M
July 9, 2025
 · 
1 min read
 · 
Dan Samorodnitsky
Big fish with dollar sign eating many small ones. Competition, merger, business, monopoly concept. EPS 8 vector illustration, no transparency
M&A
Merck Makes Big Respiratory Play With $10B Acquisition of Verona
July 9, 2025
 · 
2 min read
 · 
Tristan Manalac
People standing on cracked ground. Concept vector illustration, sketch
Weight loss
Novo Nordisk’s Termination of Hims & Hers Deal Reignites Compounding Row
July 9, 2025
 · 
4 min read
 · 
Annalee Armstrong